X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (161) 161
humans (150) 150
cystic fibrosis (94) 94
female (91) 91
male (87) 87
respiratory system (81) 81
abridged index medicus (70) 70
pediatrics (68) 68
child (59) 59
adolescent (48) 48
adult (45) 45
children (42) 42
infant, newborn (41) 41
infant (39) 39
infants (35) 35
child, preschool (32) 32
cystic fibrosis - genetics (32) 32
inflammation (31) 31
cystic fibrosis - physiopathology (28) 28
cystic fibrosis - complications (27) 27
cystic fibrosis - drug therapy (27) 27
critical care medicine (26) 26
cystic fibrosis - diagnosis (25) 25
cystic fibrosis - metabolism (23) 23
diagnosis (23) 23
article (22) 22
disease (22) 22
young adult (22) 22
cystic fibrosis transmembrane conductance regulator - genetics (21) 21
cystic fibrosis - microbiology (20) 20
lung-disease (19) 19
cystic fibrosis - therapy (18) 18
genotype (18) 18
middle aged (18) 18
mutation (18) 18
sputum (18) 18
infection (17) 17
research (17) 17
animals (16) 16
prospective studies (16) 16
cystic fibrosis - blood (15) 15
neonatal screening (15) 15
young-children (15) 15
biomarkers (14) 14
bronchoalveolar lavage (14) 14
pseudomonas-aeruginosa (14) 14
treatment outcome (14) 14
cystic-fibrosis (13) 13
lung - physiopathology (13) 13
pulmonary-function (13) 13
sputum - microbiology (13) 13
airway inflammation (12) 12
expression (12) 12
fibrosis (12) 12
pseudomonas aeruginosa (12) 12
pulmonary/respiratory (12) 12
respiratory tract diseases (12) 12
analysis (11) 11
cystic fibrosis - epidemiology (11) 11
cystic fibrosis - immunology (11) 11
disease progression (11) 11
double-blind method (11) 11
forced expiratory volume (11) 11
physiological aspects (11) 11
pulmonary exacerbation (11) 11
cystic fibrosis - pathology (10) 10
cystic fibrosis transmembrane conductance regulator - metabolism (10) 10
follow-up studies (10) 10
lung diseases (10) 10
lung-function (10) 10
multidisciplinary sciences (10) 10
respiratory function tests (10) 10
severity of illness index (10) 10
studies (10) 10
adults (9) 9
care and treatment (9) 9
cohort studies (9) 9
genetic aspects (9) 9
health aspects (9) 9
identification (9) 9
infections (9) 9
medicine (9) 9
neonatal screening - methods (9) 9
newborn screening (9) 9
proteins (9) 9
research article (9) 9
retrospective studies (9) 9
risk factors (9) 9
sweat - chemistry (9) 9
time factors (9) 9
administration, inhalation (8) 8
age factors (8) 8
anti-bacterial agents - therapeutic use (8) 8
bacteria (8) 8
biomarkers - analysis (8) 8
case-control studies (8) 8
clinical trials (8) 8
cross-sectional studies (8) 8
gene (8) 8
lung (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet Respiratory Medicine, ISSN 2213-2600, 07/2018, Volume 6, Issue 7, pp. 483 - 484
Journal Article
Journal of Cystic Fibrosis, ISSN 1569-1993, 11/2018, Volume 17, Issue 6, pp. 760 - 768
Pulmonary exacerbations (PEx) in children with cystic fibrosis (CF) are frequently treated in the outpatient setting with oral antibiotics. However, little is... 
Infection | Cystic fibrosis | Inflammation | Lung function | Pulmonary exacerbation | DENSITY | INFECTIONS | SPUTUM | RESPIRATORY SYSTEM | INTRAVENOUS ANTIBIOTICS | FEV1 | DECLINE | Pediatric pharmacology | Antibiotics
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2010, Volume 363, Issue 21, pp. 1991 - 2003
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2013, Volume 8, Issue 4, pp. e62917 - e62917
Background: Pulmonary exacerbations (PEx), frequently associated with airway infection and inflammation, are the leading cause of morbidity in cystic fibrosis... 
INFECTIONS | ANTIBIOTICS | SPUTUM | MULTIDISCIPLINARY SCIENCES | BACTERIAL COMMUNITIES | DESMOSINE | BARCODED PRIMERS | SAMPLES | FEV1 DECLINE | IDENTIFICATION | CHILDREN | Sputum - microbiology | Cystic Fibrosis - physiopathology | Humans | Bacteria - drug effects | Male | Respiratory System - microbiology | Young Adult | Anti-Bacterial Agents - therapeutic use | Inflammation - complications | Inflammation - drug therapy | Bacteria - classification | Adult | Female | Child | Inflammation - microbiology | Cross-Sectional Studies | Cystic Fibrosis - microbiology | Cystic Fibrosis - complications | Bacteria - genetics | Adolescent | Respiratory System - physiopathology | Anti-Bacterial Agents - pharmacology | Respiratory Function Tests | Metagenome | Cystic Fibrosis - drug therapy | Infection | C-reactive protein | Microbiota (Symbiotic organisms) | RNA | Analysis | Cystic fibrosis | Pulmonary function tests | Inflammation | Health aspects | Pediatrics | Respiratory function | rRNA 16S | Lung | Variability | Pseudomonas | Respiratory tract | Microbiota | Anaerobes | Bacteria | Elastase | Interleukin 8 | Deoxyribonucleic acid--DNA | Sequences | Lung diseases | Hospitalization | Morbidity | Medicine | Antibiotics | Fibrosis | Sputum | Relative abundance | Biomarkers | Anaerobic treatment | Index Medicus | Deoxyribonucleic acid | DNA
Journal Article
Journal of Pediatrics, The, ISSN 0022-3476, 2008, Volume 153, Issue 2, pp. S4 - S14
Journal Article
Journal Article
Journal Article
Thorax, ISSN 0040-6376, 01/2012, Volume 67, Issue 1, pp. 12 - 18
Journal Article
Respiratory Research, ISSN 1465-9921, 02/2014, Volume 15, Issue 1
Smoking-induced chronic obstructive pulmonary disease (COPD) is associated with acquired systemic cystic fibrosis transmembrane conductance regulator (CFTR)... 
Lung diseases | Analysis | Pediatrics | Disease | Pathogenesis | Clinical trials | Cystic fibrosis | Cigarettes | Defects | Studies | Human subjects | Chronic obstructive pulmonary disease | Mutation | Age | Smoking
Journal Article
Pediatric Pulmonology, ISSN 8755-6863, 07/2015, Volume 50, Issue 7, pp. 638 - 646
Journal Article
17.